肝炎治療薬の世界市場レポート 2024年Hepatitis Drugs Global Market Report 2024 The Business Research Companyの肝炎治療薬の世界市場レポート2024は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。 このレポートは、力強い成長を遂げて... もっと見る
サマリーThe Business Research Companyの肝炎治療薬の世界市場レポート2024は、戦略担当者、マーケティング担当者、経営幹部が市場を評価するために必要な重要情報を提供します。このレポートは、力強い成長を遂げている肝炎治療薬市場に焦点を当てています。今後10年間およびそれ以降の市場を形成するトレンドのガイドを提供します。 購入の理由 - 50以上の地域をカバーするこの市場に関する最も包括的なレポートにより、真のグローバルな視点を得ることができます。 - 市場がCOVID-19の影響をどのように受けてきたか、またウイルスの影響が和らぐにつれて市場がどのように対応しているかを理解する。 - ロシア・ウクライナ戦争が農業、エネルギー、鉱物資源供給に与える影響と、市場への直接的・間接的影響を評価する。 - 世界的な高インフレが市場成長に与える影響を測定する。 - 現地のデータと分析に基づき、地域戦略と国別戦略を策定する。 - 投資の対象となる成長セグメントを特定する。 - 予測データと市場を形成する原動力とトレンドを活用し、競合他社を凌駕する。 - 最新の市場シェアに基づいて顧客を理解する。 - 主要な競合他社に対する業績のベンチマーク - 信頼性の高い高品質のデータと分析により、社内外でのプレゼンテーションをサポートするのに適しています。 - レポートは最新データに更新され、データ抽出と分析が簡単にできるExcelデータシートとともに、ご注文から3~5営業日以内にお届けします。 - レポートの全データは、エクセルのダッシュボード形式でも納品されます。 説明 肝炎治療薬の最大かつ最速の成長市場はどこか?経済全体、人口動態、他の類似市場との関連は?今後の市場を形成する勢力は何か?ビジネスリサーチ社の肝炎治療薬世界市場レポートでは、これらの疑問やその他多くの疑問にお答えします。 本レポートでは、市場の特徴、規模および成長、セグメンテーション、地域別および国別内訳、競合情勢、市場シェア、トレンド、戦略を網羅しています。地域別に市場の過去および予測市場成長を追跡します。 調査範囲 対象市場:1) 薬剤クラス別インターフェロンアルファ;HIV NRTI;ヌクレオチドポリメラーゼ/NS5A阻害剤配合剤;C型肝炎プロテアーゼ/NS5A阻害剤配合剤;NS5A阻害剤;ヌクレオチドポリメラーゼ阻害剤;ヌクレオシドアナログ抗ウイルス剤;血栓溶解促進剤 2) 投与経路別経口;注射 3) 販売チャネル別病院薬局;小売薬局;オンライン薬局 4) 用途別A型肝炎;B型肝炎;C型肝炎;D型肝炎;E型肝炎 言及された企業Gilead Sciences Inc.、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline plc、Johnson & Johnson、Merck & Co.Inc. 国オーストラリア、ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、ロシア、韓国、英国、米国、カナダ、イタリア、スペイン 地域アジア太平洋; 西ヨーロッパ; 東ヨーロッパ; 北アメリカ; 南アメリカ; 中東; アフリカ 時系列:過去5年間および過去10年間の予測。 データ市場規模と成長率の関連市場に対する比率、GDP比率、一人当たり支出、 データ区分:国別・地域別の過去データと予測データ、競合他社の市場シェア、市場セグメント。 ソーシングと参照:本レポート中のデータおよび分析は、エンドノートを使用しています。 納品形式PDF、Word、Excel データダッシュボード。 目次1. Executive Summary2. Hepatitis Drugs Market Characteristics 3. Hepatitis Drugs Market Trends And Strategies 4. Hepatitis Drugs Market - Macro Economic Scenario 4.1. Impact Of High Inflation On The Market 4.2. Ukraine-Russia War Impact On The Market 4.3. COVID-19 Impact On The Market 5. Global Hepatitis Drugs Market Size and Growth 5.1. Global Hepatitis Drugs Market Drivers and Restraints 5.1.1. Drivers Of The Market 5.1.2. Restraints Of The Market 5.2. Global Hepatitis Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion) 5.3. Global Hepatitis Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion) 6. Hepatitis Drugs Market Segmentation 6.1. Global Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion Interferon Alphas HIV NRTIs Nucleotide Polymerase/NS5A Inhibitor Combinations Hepatitis C Protease/NS5A Inhibitor Combinations NS5A Inhibitors Nucleotide Polymerase Inhibitors Nucleoside Analogue Antivirals Thrombopoiesis Stimulating Agents 6.2. Global Hepatitis Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion Oral Injection 6.3. Global Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion Hospital Pharmacies Retail Pharmacies Online Pharmacies 6. 4. Global Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E 7. Hepatitis Drugs Market Regional And Country Analysis 7.1. Global Hepatitis Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 7.2. Global Hepatitis Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 8. Asia-Pacific Hepatitis Drugs Market 8.1. Asia-Pacific Hepatitis Drugs Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 8.3. Asia-Pacific Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 8. 4. Asia-Pacific Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 9. China Hepatitis Drugs Market 9.1. China Hepatitis Drugs Market Overview 9.2. China Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion 9.3. China Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion 9. 4. China Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion 10. India Hepatitis Drugs Market 10.1. India Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 10.2. India Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 10.3. India Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 11. Japan Hepatitis Drugs Market 11.1. Japan Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 11.2. Japan Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 11.3. Japan Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 12. Australia Hepatitis Drugs Market 12.1. Australia Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 12.2. Australia Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 12.3. Australia Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 13. Indonesia Hepatitis Drugs Market 13.1. Indonesia Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 13.2. Indonesia Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 13.3. Indonesia Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 14. South Korea Hepatitis Drugs Market 14.1. South Korea Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 14.2. South Korea Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 14.3. South Korea Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 15. Western Europe Hepatitis Drugs Market 15.1. Western Europe Hepatitis Drugs Market Overview 15.2. Western Europe Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 15.3. Western Europe Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 15. 4. Western Europe Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 16. UK Hepatitis Drugs Market 16.1. UK Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 16.2. UK Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 16.3. UK Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 17. Germany Hepatitis Drugs Market 17.1. Germany Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 17.2. Germany Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 17.3. Germany Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 18. France Hepatitis Drugs Market 18. 5. France Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 18. 6. France Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 18. 7. France Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 19. Italy Hepatitis Drugs Market 19. 9. Italy Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 19.10. Italy Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 19.11. Italy Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 20. Spain Hepatitis Drugs Market 20.13. Spain Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 20.14. Spain Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 20.15. Spain Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 21. Eastern Europe Hepatitis Drugs Market 21.1. Eastern Europe Hepatitis Drugs Market Overview 21.2. Eastern Europe Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 21.3. Eastern Europe Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 21. 4. Eastern Europe Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 22. Russia Hepatitis Drugs Market 22.1. Russia Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 22.2. Russia Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 22.3. Russia Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 23. North America Hepatitis Drugs Market 23.1. North America Hepatitis Drugs Market Overview 23.2. North America Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 23.3. North America Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 23. 4. North America Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 24. USA Hepatitis Drugs Market 24.1. USA Hepatitis Drugs Market Overview 24.2. USA Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 24.3. USA Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 24. 4. USA Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 25. Canada Hepatitis Drugs Market 25.1. Canada Hepatitis Drugs Market Overview 25.2. Canada Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 25.3. Canada Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 25. 4. Canada Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 26. South America Hepatitis Drugs Market 26.1. South America Hepatitis Drugs Market Overview 26.2. South America Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 26.3. South America Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 26. 4. South America Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 27. Brazil Hepatitis Drugs Market 27.1. Brazil Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 27.2. Brazil Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 27.3. Brazil Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 28. Middle East Hepatitis Drugs Market 28.1. Middle East Hepatitis Drugs Market Overview 28.2. Middle East Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 28.3. Middle East Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 28. 4. Middle East Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 29. Africa Hepatitis Drugs Market 29.1. Africa Hepatitis Drugs Market Overview 29.2. Africa Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 29.3. Africa Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 29. 4. Africa Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 30. Hepatitis Drugs Market Competitive Landscape And Company Profiles 30.1. Hepatitis Drugs Market Competitive Landscape 30.2. Hepatitis Drugs Market Company Profiles 30.2.1. Gilead Sciences Inc. 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1. 4. Financial Performance 30.2.2. F. Hoffmann-La Roche Ltd 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2. 4. Financial Performance 30.2.3. GlaxoSmithKline plc 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3. 4. Financial Performance 30.2. 4. Johnson & Johnson 30.2. 4.1. Overview 30.2. 4.2. Products and Services 30.2. 4.3. Strategy 30.2. 4. 4. Financial Performance 30.2. 5. Merck & Co. Inc. 30.2. 5.1. Overview 30.2. 5.2. Products and Services 30.2. 5.3. Strategy 30.2. 5. 4. Financial Performance 31. Global Hepatitis Drugs Market Competitive Benchmarking 32. Global Hepatitis Drugs Market Competitive Dashboard 33. Key Mergers And Acquisitions In The Hepatitis Drugs Market 34. Hepatitis Drugs Market Future Outlook and Potential Analysis 34.1 Hepatitis Drugs Market In 2028 - Countries Offering Most New Opportunities 34.2 Hepatitis Drugs Market In 2028 - Segments Offering Most New Opportunities 34. 3 Hepatitis Drugs Market In 2028 - Growth Strategies 34.3.1 Market Trend Based Strategies 34.3.2 Competitor Strategies 35. Appendix 35.1. Abbreviations 35.2. Currencies 35.3. Historic And Forecast Inflation Rates 35. 4. Research Inquiries 35. 5. The Business Research Company 35. 6. Copyright And Disclaimer
SummaryHepatitis Drugs Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. Table of Contents1. Executive Summary2. Hepatitis Drugs Market Characteristics 3. Hepatitis Drugs Market Trends And Strategies 4. Hepatitis Drugs Market - Macro Economic Scenario 4.1. Impact Of High Inflation On The Market 4.2. Ukraine-Russia War Impact On The Market 4.3. COVID-19 Impact On The Market 5. Global Hepatitis Drugs Market Size and Growth 5.1. Global Hepatitis Drugs Market Drivers and Restraints 5.1.1. Drivers Of The Market 5.1.2. Restraints Of The Market 5.2. Global Hepatitis Drugs Historic Market Size and Growth, 2018 - 2023, Value ($ Billion) 5.3. Global Hepatitis Drugs Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion) 6. Hepatitis Drugs Market Segmentation 6.1. Global Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion Interferon Alphas HIV NRTIs Nucleotide Polymerase/NS5A Inhibitor Combinations Hepatitis C Protease/NS5A Inhibitor Combinations NS5A Inhibitors Nucleotide Polymerase Inhibitors Nucleoside Analogue Antivirals Thrombopoiesis Stimulating Agents 6.2. Global Hepatitis Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion Oral Injection 6.3. Global Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion Hospital Pharmacies Retail Pharmacies Online Pharmacies 6. 4. Global Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E 7. Hepatitis Drugs Market Regional And Country Analysis 7.1. Global Hepatitis Drugs Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 7.2. Global Hepatitis Drugs Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 8. Asia-Pacific Hepatitis Drugs Market 8.1. Asia-Pacific Hepatitis Drugs Market Overview Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies 8.2. Asia-Pacific Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 8.3. Asia-Pacific Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 8. 4. Asia-Pacific Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 9. China Hepatitis Drugs Market 9.1. China Hepatitis Drugs Market Overview 9.2. China Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion 9.3. China Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion 9. 4. China Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion 10. India Hepatitis Drugs Market 10.1. India Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 10.2. India Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 10.3. India Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 11. Japan Hepatitis Drugs Market 11.1. Japan Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 11.2. Japan Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 11.3. Japan Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 12. Australia Hepatitis Drugs Market 12.1. Australia Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 12.2. Australia Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 12.3. Australia Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 13. Indonesia Hepatitis Drugs Market 13.1. Indonesia Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 13.2. Indonesia Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 13.3. Indonesia Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 14. South Korea Hepatitis Drugs Market 14.1. South Korea Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 14.2. South Korea Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 14.3. South Korea Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 15. Western Europe Hepatitis Drugs Market 15.1. Western Europe Hepatitis Drugs Market Overview 15.2. Western Europe Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 15.3. Western Europe Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 15. 4. Western Europe Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 16. UK Hepatitis Drugs Market 16.1. UK Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 16.2. UK Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 16.3. UK Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 17. Germany Hepatitis Drugs Market 17.1. Germany Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 17.2. Germany Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 17.3. Germany Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 18. France Hepatitis Drugs Market 18. 5. France Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 18. 6. France Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 18. 7. France Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 19. Italy Hepatitis Drugs Market 19. 9. Italy Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 19.10. Italy Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 19.11. Italy Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 20. Spain Hepatitis Drugs Market 20.13. Spain Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 20.14. Spain Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 20.15. Spain Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 21. Eastern Europe Hepatitis Drugs Market 21.1. Eastern Europe Hepatitis Drugs Market Overview 21.2. Eastern Europe Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 21.3. Eastern Europe Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 21. 4. Eastern Europe Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 22. Russia Hepatitis Drugs Market 22.1. Russia Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 22.2. Russia Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 22.3. Russia Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 23. North America Hepatitis Drugs Market 23.1. North America Hepatitis Drugs Market Overview 23.2. North America Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 23.3. North America Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 23. 4. North America Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 24. USA Hepatitis Drugs Market 24.1. USA Hepatitis Drugs Market Overview 24.2. USA Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 24.3. USA Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 24. 4. USA Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 25. Canada Hepatitis Drugs Market 25.1. Canada Hepatitis Drugs Market Overview 25.2. Canada Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 25.3. Canada Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 25. 4. Canada Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 26. South America Hepatitis Drugs Market 26.1. South America Hepatitis Drugs Market Overview 26.2. South America Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 26.3. South America Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 26. 4. South America Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 27. Brazil Hepatitis Drugs Market 27.1. Brazil Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 27.2. Brazil Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 27.3. Brazil Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 28. Middle East Hepatitis Drugs Market 28.1. Middle East Hepatitis Drugs Market Overview 28.2. Middle East Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 28.3. Middle East Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 28. 4. Middle East Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 29. Africa Hepatitis Drugs Market 29.1. Africa Hepatitis Drugs Market Overview 29.2. Africa Hepatitis Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 29.3. Africa Hepatitis Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 29. 4. Africa Hepatitis Drugs Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion 30. Hepatitis Drugs Market Competitive Landscape And Company Profiles 30.1. Hepatitis Drugs Market Competitive Landscape 30.2. Hepatitis Drugs Market Company Profiles 30.2.1. Gilead Sciences Inc. 30.2.1.1. Overview 30.2.1.2. Products and Services 30.2.1.3. Strategy 30.2.1. 4. Financial Performance 30.2.2. F. Hoffmann-La Roche Ltd 30.2.2.1. Overview 30.2.2.2. Products and Services 30.2.2.3. Strategy 30.2.2. 4. Financial Performance 30.2.3. GlaxoSmithKline plc 30.2.3.1. Overview 30.2.3.2. Products and Services 30.2.3.3. Strategy 30.2.3. 4. Financial Performance 30.2. 4. Johnson & Johnson 30.2. 4.1. Overview 30.2. 4.2. Products and Services 30.2. 4.3. Strategy 30.2. 4. 4. Financial Performance 30.2. 5. Merck & Co. Inc. 30.2. 5.1. Overview 30.2. 5.2. Products and Services 30.2. 5.3. Strategy 30.2. 5. 4. Financial Performance 31. Global Hepatitis Drugs Market Competitive Benchmarking 32. Global Hepatitis Drugs Market Competitive Dashboard 33. Key Mergers And Acquisitions In The Hepatitis Drugs Market 34. Hepatitis Drugs Market Future Outlook and Potential Analysis 34.1 Hepatitis Drugs Market In 2028 - Countries Offering Most New Opportunities 34.2 Hepatitis Drugs Market In 2028 - Segments Offering Most New Opportunities 34. 3 Hepatitis Drugs Market In 2028 - Growth Strategies 34.3.1 Market Trend Based Strategies 34.3.2 Competitor Strategies 35. Appendix 35.1. Abbreviations 35.2. Currencies 35.3. Historic And Forecast Inflation Rates 35. 4. Research Inquiries 35. 5. The Business Research Company 35. 6. Copyright And Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医薬)の最新刊レポート
The Business Research Company (TBRC)社の医薬分野での最新刊レポート
本レポートと同じKEY WORD(hepatitis drugs)の最新刊レポートよくあるご質問The Business Research Company (TBRC)社はどのような調査会社ですか?The Business Research Company (TBRC)はインドを主要拠点に世界の多様な市場を調査・予測し、調査レポートを積極的に出版しています。調査対象には技術、ライフサイエンス、重... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |